Clinical Trial Update: Safety and Tolerability of Varenicline in Schizophrenia (SATOVA) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the safety and tolerability of varenicline in schizophrenia and schizoaffective disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Varenicline (Chantix) (varenicline)

Snippet

Sponsor: University of British Columbia | Conditions: Schizophrenia, Schizoaffective | Phase 4 | Status: WITHDRAWN